ClassID:

170476

G01N2333/705 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving receptors, cell surface antigens or cell surface determinants

Sub-classes:
Recent Application in this class:
#1
20260144904
2026-05-28

Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds

#2
20260126440
2026-05-07

METHODS FOR MEASURING LYMPHOCYTE ACTIVITY

#3
20260118368
2026-04-30

DETECTING CANCER

#4
20260086036
2026-03-26

SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING

#5
20260085104
2026-03-26

METHODS OF DETECTING IMMUNE CELLS

#6
20260085091
2026-03-26

PEPTIDES THAT SELECTIVELY BIND TO Trop2 AND USE THEREOF

#7
20260036593
2026-02-05

DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS

#8
20260016489
2026-01-15

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

#9
20250389712
2025-12-25

DYNAMIC CLAMPS AND METHODS OF USE THEREOF

#10
20250383356
2025-12-18

METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT

#11
20250382656
2025-12-18

CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS

#12
20250368728
2025-12-04

ANTIBODIES FOR DETECTION AND ENRICHMENT OF FETAL CELLS AND THEIR USE

#13
20250361504
2025-11-27

SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS

#14
20250327806
2025-10-23

METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT

#15
20250326834
2025-10-23

COMBINATION THERAPY OF CLAUDIN 18.2 ANTAGONIST AND PD-1/PD-L1 AXIS INHIBITOR

#16
20250314663
2025-10-09

METHODS FOR TREATING ACUTE KIDNEY INJURY

#17
20250313647
2025-10-09

MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE

#18
20250297214
2025-09-25

METHODS FOR ISOLATING NEURAL STEM AND PROGENITOR CELLS FROM THE DEVELOPING HUMAN BRAIN

#19
20250277790
2025-09-04

QUANTIFICATION OF LIGAND BIAS AND MUTATION-INDUCED SIGNALING BIAS IN EGFR PHOSPHORYLATION IN DIRECT RESPONSE TO LIGAND BINDING

#20
20250277784
2025-09-04

EXPRESSION SYSTEMS FOR THE ALPHA6BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF

#21
20250277026
2025-09-04

ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF

#22
20250270313
2025-08-28

CLDN18.2 ANTIBODY AND USE THEREOF

#23
20250264461
2025-08-21

NANOVESICLE COMPRISING HETERODIMERIC G-PROTEIN COUPLED RECEPTOR, METHOD FOR PREPARING NANOVESICLE, FIELD EFFECT TRANSISTOR-BASED TASTE SENSOR COMPRISING NANOVESICLE, AND METHOD FOR MANUFACTURING TASTE SENSOR

#24
20250235501
2025-07-24

Methods and Compositions for Treating or Preventing Neurological Injury or Neurological Disorders

#25
20250231200
2025-07-17

Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases

#26
20250231178
2025-07-17

A BIOMARKER FOR DETERMINING ALZHEIMER'S DISEASE

#27
20250231176
2025-07-17

OLFACTORY RECEPTOR GENE FOR DIAGNOSING SKIN AGING AND USE THEREOF

#28
20250208133
2025-06-26

SENESCENT CELL SURFACE MARKERS

#29
20250208131
2025-06-26

Diagnosis of Congenital Heart Block

#30
20250201405
2025-06-19

METHOD FOR PREDICTING PROGNOSTIC INDICATIONS OF PANCREATIC CANCER PATIENTS

#31
20250197920
2025-06-19

MULTI-OMIC DETERMINATION OF FERTILITY FITNESS

#32
20250180582
2025-06-05

MARKER FOR DIAGNOSING MULTIPLE SCLEROSIS AND USE THEREOF

#33
20250180552
2025-06-05

ANALYTE QUANTITATION

#34
20250155427
2025-05-15

CELLS EXPRESSING UMAMI TASTE RECEPTORS AND USES THEREOF

#35
20250152632
2025-05-15

RENAL CELL POPULATIONS AND USES THEREOF

#36
20250146939
2025-05-08

SERS NANO-PARTICLE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF TO METHOD FOR DISTINGUISHING CTCS FROM WBCS

#37
20250145706
2025-05-08

ANTIBODIES TARGETING THE B-CELL RECEPTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USES THEREOF

#38
20250136679
2025-05-01

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

#39
20250127818
2025-04-24

COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES

#40
20250122280
2025-04-17

ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF

#41
20250115899
2025-04-10

BISTABLE POLYNUCLEOTIDE DEVICES FOR THE SENSING AND QUANTIFICATION OF MOLECULAR EVENTS

#42
20250093351
2025-03-20

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

#43
20250092130
2025-03-20

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

#44
20250076312
2025-03-06

BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE

#45
20250057979
2025-02-20

CARDIAC CALCIUM HANDLING MACHINERY REMODELED IN FRIEDREICH'S ATAXIA

#46
20250052768
2025-02-13

IN VITRO METHODS FOR DETECTING DLL1

#47
20250051437
2025-02-13

CDH17 ANTIBODIES AND METHODS OF TREATING CANCER

#48
20250044303
2025-02-06

PROTEIN BIOMARKER INDICATORS OF NEUROLOGICAL INJURY AND/OR DISEASE AND METHODS OF USE THEREOF

#49
20250035617
2025-01-30

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

#50
20250035615
2025-01-30

METHODS FOR ISOLATING SURFACE MARKER DISPLAYING AGENTS

#51
20250032453
2025-01-30

20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE

#52
20250027166
2025-01-23

SYSTEMS AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES

#53
20250020663
2025-01-16

METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION

#54
20250020661
2025-01-16

RATIOS OF sFlt-1 TO P1GF OR ENDOGLIN TO P1GF AS BIOMARKERS FOR PREECLAMPSIA RELATED ADVERSE OUTCOMES AFTER BIRTH

#55
20250019406
2025-01-16

SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES

#56
20250012809
2025-01-09

Tissue-Specific Extracellular Vesicle Isolation and Validation

#57
20250002576
2025-01-02

CLAUDIN 18.2-BINDING ANTIBODIES AND FRAGMENTS THEREOF

#58
20240415921
2024-12-19

METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES

#59
20240410893
2024-12-12

COMPOSITIONS, SYSTEMS, AND METHODS FOR DETERMINATION OF T2R AND/OR T1R PHENOTYPE IN INDIVIDUALS TO PREDICT CANNABIS TASTING PREFERENCES, CHARACTERIZATION OF CANNABIS IN RELATION TO INDIVIDUAL TASTING PREFERENCES, AND SELECTION OF CANNABIS

#60
20240402171
2024-12-05

CORNEAL ENDOTHELIAL CELL MARKER

#61
20240400718
2024-12-05

ANTIBODY BINDING TO LINKER OF scFv OR LIKE

#62
20240393338
2024-11-28

TIBTECH COMPOSITIONS AND METHODS FOR DETECTING CDH17

#63
20240385174
2024-11-21

METHOD FOR SCREENING SUBSTANCE THAT SUPPRESSES 4-METHYLACETOPHENONE ODOR, AND METHOD FOR SUPPRESSING 4-METHYL ACETOPHENONE ODOR

#64
20240384344
2024-11-21

METHOD FOR LABELING CELLS

#65
20240368302
2024-11-07

ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF

#66
20240353424
2024-10-24

BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME

#67
20240353415
2024-10-24

METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS

#68
20240353396
2024-10-24

COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING

#69
20240327510
2024-10-03

DRUG FOR PREVENTING, ALLEVIATING OR TREATING MUCOSAL ADHESION AND USE THEREOF

#70
20240319179
2024-09-26

MULTIPLEXED NANO-BIOSENSOR SYSTEM FOR EARLY DETECTION OF DIABETES

#71
20240307325
2024-09-19

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS

#72
20240295560
2024-09-05

PANCREATIC CANCER DIAGNOSIS ASSISTANCE METHOD AND PHARMACEUTICAL COMPOUND FOR TREATING PANCREATIC CANCER

#73
20240293460
2024-09-05

DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE

#74
20240272164
2024-08-15

METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR

#75
20240269668
2024-08-15

Systems and Methods for Assessment of Lipid Membrane-Associated Molecule Kinetics, Dynamics, and Interactions

#76
20240264174
2024-08-08

METHOD FOR EVALUATING RISK OF ACUTE CEREBRAL VASCULAR DISEASE USING SOLUBLE CLEC2

#77
20240248091
2024-07-25

MEANS AND METHODS FOR THE DIAGNOSIS, CLASSIFICATION AND/OR MONITORING OF PEDIATRIC TUMORS

#78
20240239903
2024-07-18

PATCHED-1 MONOCLONAL ANTIBODIES AND METHODS OF USE

#79
20240226312
2024-07-11

TREATMENT OF CANCER IN PATIENTS WITH SOLUBLE FR-ALPHA

#80
20240209091
2024-06-27

METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES

#81
20240201188
2024-06-20

A 3-LASER 13-COLOR B CELL MONITORING PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS

#82
20240168015
2024-05-23

METHOD FOR THE DETECTION OF ORGAN DERIVED EXTRACELLULAR VESICLES

#83
20240166742
2024-05-23

MOLECULES THAT BIND TO AND STABILIZE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 (TREM2)

#84
20240159774
2024-05-16

DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS

#85
20240158429
2024-05-16

NOVEL TRIAZINE-BASED AMPHIPHILIC COMPOUND AND USE THEREOF

#86
20240150838
2024-05-09

METHOD FOR DETECTING OR QUANTIFYING PHOTOAGED CELLS, APPLICATION OF SAME, AND METHOD FOR PREPARING PHOTOAGED CELLS

#87
20240142471
2024-05-02

TEST FOR MILD COGNITIVE IMPAIRMENT

#88
20240141036
2024-05-02

Epitope of Regulatory T Cell Surface Antigen, and Antibody Specifically Binding Thereto

#89
20240123025
2024-04-18

LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES

#90
20240118268
2024-04-11

BIOMARKERS ON CELLULAR ENDOCRINE MODELS FOR ENDOCRINE DISRUPTION ASSESSMENT

#91
20240117055
2024-04-11

ANTIBODIES THAT BIND TO AXL PROTEINS

#92
20240102090
2024-03-28

METHOD FOR MULTIMODAL PROFILING OF INDIVIDUAL EXTRACELLULAR VESICLES

#93
20240101663
2024-03-28

METHOD FOR INHIBITING TUMOUR CELL GROWTH BASED ON CCDC112

#94
20240092766
2024-03-21

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#95
20240091272
2024-03-21

ENGINEERED MULTICELLULAR ORGANISMS

#96
20240076390
2024-03-07

ANTIBODIES THAT BIND TO AXL PROTEINS

#97
20240076370
2024-03-07

ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE

#98
20240060975
2024-02-22

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

#99
20240044872
2024-02-08

METHOD FOR ASSESSING THE OPSONOPHAGOCYTOTIC CAPACITY OR TROGOCYTOTIC CAPACITY OF AN ANTIGEN-BINDING MOLECULE

#100
20240041831
2024-02-08

20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE

#101
20240036061
2024-02-01

METHODS FOR THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS

#102
20240016772
2024-01-18

Compositions And Methods Comprising D-Cysteine Or A D-Derivative Thereof

#103
20240012006
2024-01-11

A METHOD OF EVALUATING SPERM HEALTH AND IDENTIFYING SPERM TO BE USED IN ASSIS REPRODUCTIVE TECHNOLOGIES

#104
20240011992
2024-01-11

Methods, Compositions, and Systems for Modulation of Coronavirus Infection

#105
20240003905
2024-01-04

METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MODULATING TEMPERATURE AND PRODUCING ANALYTE IMAGING DATA

#106
20230417767
2023-12-28

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#107
20230408525
2023-12-21

MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS

#108
20230406902
2023-12-21

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

#109
20230393147
2023-12-07

METHODS FOR IDENTIFYING AND TREATING ANTIBODY-MEDIATED ACQUIRED PRIMARY OR RECURRENT IDIOPATHIC NEPHROTIC SYNDROME

#110
20230392157
2023-12-07

APTAMER METHOD

#111
20230374106
2023-11-23

Methods and Devices For Complexing Target Entities

#112
20230366875
2023-11-16

GPCR19-P2XN RECEPTOR COMPLEX AND USE THEREOF

#113
20230364085
2023-11-16

USE OF MODULATORS OF CCR5 IN THE TREATMENT OF CANCER AND CANCER METASTASIS

#114
20230349887
2023-11-02

METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE

#115
20230348591
2023-11-02

METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF

#116
20230333106
2023-10-19

COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS

#117
20230313134
2023-10-05

Human otic progenitor identification and isolation

#118
20230312707
2023-10-05

METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF

#119
20230279083
2023-09-07

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#120
20230273205
2023-08-31

Methods and Compositions for Diagnosing and Treating Cancer

#121
20230272111
2023-08-31

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof

#122
20230265183
2023-08-24

ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF

#123
20230243825
2023-08-03

ADAPTIVE NANOPARTICLE PLATFORMS FOR HIGH THROUGHPUT EXPANSION AND DETECTION OF ANTIGEN-SPECIFIC T CELLS

#124
20230242667
2023-08-03

MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS

#125
20230235031
2023-07-27

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#126
20230233551
2023-07-27

COMPOSITIONS AND METHODS FOR TREATMENT

#127
20230228768
2023-07-20

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

#128
20230221324
2023-07-13

BIOSENSING DEVICE FOR DETECTING CANCER

#129
20230221316
2023-07-13

USE OF AUTOMATED PLATFORMS FOR PREPARATION OF BIOMARKER AND ROMANOWSKY-TYPE STAINED SAMPLE PRINTED ON A SLIDE

#130
20230221315
2023-07-13

DEVICE OR METHOD FOR DETECTION OF LEUKOCYTE IN DISEASE STATE OR FOR DIAGNOSIS OF LEUKOCYTE-RELATED DISEASE

#131
20230213524
2023-07-06

DIAGNOSTIC ASSAYS AND KITS FOR DETECTION OF FOLATE RECEPTOR 1

#132
20230213513
2023-07-06

Neutrophil Progenitors and Related Methods and Uses

#133
20230204579
2023-06-29

Immune Cell Biomarkers of Cardiovascular Disease

#134
20230194553
2023-06-22

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

#135
20230194524
2023-06-22

Stem Cell Memory T Cells, Methods and Uses for Modulating Inflammatory Responses, and Diagnosing and Treating Adverse Cardiovascular Events and Disease

#136
20230184776
2023-06-15

METHOD OF ISOLATING CIRCULATING TUMOR CELLS

#137
20230168260
2023-06-01

METHOD FOR MEASURING PLATELET ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELET COUNT

#138
20230144625
2023-05-11

POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYN-DROMES

#139
20230140453
2023-05-04

METHOD FOR CONTROLLING OBESITY BY REGULATING ACTIVITY OF TREK1

#140
20230127655
2023-04-27

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#141
20230100634
2023-03-30

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#142
20230096203
2023-03-30

METHODS FOR DETECTING FOOD ALLERGIES

#143
20230078745
2023-03-16

Blood biomarkers and diagnostic methods for small vessel diseases

#144
20230065632
2023-03-02

CYTOMETRIC ASSAYS

#145
20230025572
2023-01-26

HIGH AVIDITY ANTIGEN RECOGNIZING CONSTRUCTS

#146
20230003717
2023-01-05

USE OF SYNAPTOTAGMIN-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER

#147
20220411410
2022-12-29

Modulators of ATP-binding cassette transporters

#148
20220381787
2022-12-01

NOVEL LOX-1 ANTIBODY COMPOSITIONS, LOX1 NEUTRALIZATION ASSAY AND METHODS OF TREATMENT USING SAME

#149
20220370503
2022-11-24

METHODS AND DEVICES FOR THE PRODUCTION AND DELIVERY OF BENEFICIAL FACTORS FROM STEM CELLS

#150
20220349891
2022-11-03

METHODS FOR IDENTIFYING CANCER

#151
20220347221
2022-11-03

RENAL CELL POPULATIONS AND USES THEREOF

#152
20220341938
2022-10-27

USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE

#153
20220308063
2022-09-29

In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method

#154
20220308062
2022-09-29

METHODS FOR PREDICTING DRUG RESPONSIVENESS IN SAMPLES FROM CANCER SUBJECTS

#155
20220279777
2022-09-08

FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTICOAGULANT-INDUCED COAGULOPATHY

#156
20220268781
2022-08-25

PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS

#157
20220268702
2022-08-25

SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING

#158
20220235420
2022-07-28

COMPOSITIONS AND METHODS FOR ISOLATING, DETECTING, AND ANALYZING FETAL CELLS

#159
20220214346
2022-07-07

Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer

#160
20220205987
2022-06-30

Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation

#161
20220196652
2022-06-23

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

#162
20220195421
2022-06-23

Bistable polynucleotide devices for the sensing and quantification of molecular events

#163
20220178928
2022-06-09

GENETIC AMPLIFIED TUMOR HOMING NANOPARTICLES AND COMPOSITIONS AND METHODS THEREOF

#164
20220175977
2022-06-09

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#165
20220175875
2022-06-09

METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES

#166
20220168444
2022-06-02

INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE

#167
20220168353
2022-06-02

FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY

#168
20220163539
2022-05-26

NLRP3 INFLAMMASOME INHIBITION

#169
20220163526
2022-05-26

Senescent cell biomarkers

#170
20220163518
2022-05-26

Biomarker Detection Methods and Systems and Kits for Practicing Same

#171
20220157155
2022-05-19

Configuring a smart home controller

#172
20220144925
2022-05-12

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#173
20220137070
2022-05-05

METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS

#174
20220128573
2022-04-28

BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF

#175
20220120735
2022-04-21

Testing Methods for Determination of T2R Phenotype and Applications Thereof

#176
20220113320
2022-04-14

IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF NEURODEGENERATIVE DISORDERS

#177
20220105069
2022-04-07

Methods for treating brain metastasis

#178
20220089780
2022-03-24

KLOTHO BETA

#179
20220074944
2022-03-10

DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF

#180
20220065871
2022-03-03

AMYLOID PRECURSOR PROTEIN AS A DIAGNOSTIC MARKER FOR BILIARY ATRESIA

#181
20220064648
2022-03-03

X-aptamers for the use in detection of SNAP25

#182
20220064284
2022-03-03

Anti-idiotypic antibodies against anti-GPRC5D antibodies

#183
20220057398
2022-02-24

BIOMARKERS FOR TYPE 1 DIABETES

#184
20220047602
2022-02-17

SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING

#185
20220034866
2022-02-03

Method for screening of unpleasant odor masking agents

#186
20220026427
2022-01-27

CELL BASED ASSAYS AND KITS FOR ASSESSING SERUM CHOLINERGIC RECEPTOR ACTIVITY

#187
20220018855
2022-01-20

RGMa Fragment Based Diagnostic Assay

#188
20210396746
2021-12-23

Analyte quantitation

#189
20210389304
2021-12-16

METHODS FOR ISOLATING SURFACE MARKER DISPLAYING AGENTS

#190
20210382049
2021-12-09

ASSESSING RESPONSIVENESS OF RHEUMATOID ARTHRITIS PATIENTS TO BIOLOGICAL TREATMENT

#191
20210364532
2021-11-25

USE OF SOLUBLE TREM-1 LEVELS FOR IDENTIFYING SUBJECTS SUSCEPTIBLE TO RESPOND TO AN ANTI-INFLAMMATORY THERAPY

#192
20210364522
2021-11-25

METHODS FOR CAPTURING, ISOLATION, AND TARGETING OF CIRCULATING TUMOR CELLS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF

#193
20210363248
2021-11-25

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

#194
20210349078
2021-11-11

COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING

#195
20210340229
2021-11-04

Immuno-based botulinum toxin serotype A activity assays

#196
20210332122
2021-10-28

DYSREGULATION OF COVID-19 RECEPTOR ASSOCIATED WITH IBD

#197
20210318310
2021-10-14

METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS

#198
20210318306
2021-10-14

Compositions for and Methods of Neutralizing Lipopolysaccharide Toxicity and Methods of Identifying the Same

#199
20210311048
2021-10-07

Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host disease

#200
20210309758
2021-10-07

Antibodies to MUC16 and methods of use thereof

#201
20210293824
2021-09-23

Preeclampsia biomarkers and related systems and methods

#202
20210284753
2021-09-16

KLOTHO BETA

#203
20210277107
2021-09-09

Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detection

#204
20210270832
2021-09-02

Methods and materials for identifying and treating membranous nephropathy

#205
20210246203
2021-08-12

Astrotactin1-based compositions and pharmaceutical formulations

#206
20210231668
2021-07-29

KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY

#207
20210230553
2021-07-29

Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

#208
20210215665
2021-07-15

Dynamic clamps and methods of use thereof

#209
20210214807
2021-07-15

METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER

#210
20210199661
2021-07-01

Use of ZC3H12B gene or protein and method for establishing animal model of liver disease

#211
20210189005
2021-06-24

Antibodies against HPA-1a

#212
20210188985
2021-06-24

Antibodies that bind to AXL proteins

#213
20210188984
2021-06-24

Antibodies that bind to AXL proteins

#214
20210171655
2021-06-10

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

#215
20210171614
2021-06-10

Immuno-based botulinum toxin serotype A activity assays

#216
20210148916
2021-05-20

Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells and Compositions and Methods of Treatment of Cancer

#217
20210147510
2021-05-20

Prostate specific membrane antigen binding fibronectin type iii domains

#218
20210140965
2021-05-13

Corneal endothelial cell marker

#219
20210121583
2021-04-29

Methods of screening for sortilin binding antagonists

#220
20210116459
2021-04-22

BIOMARKERS AND USES THEREOF

#221
20210116456
2021-04-22

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER

#222
20210102233
2021-04-08

METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE

#223
20210095293
2021-04-01

METHODS OF TREATING CANCERS WITH GPR132 INHIBITORS

#224
20210079114
2021-03-18

THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS

#225
20210079090
2021-03-18

Anti-STAT3 specific antibody and the pharmaceutical composition comprising thereof

#226
20210055306
2021-02-25

Method and platform for detecting immunogenicity of tumor neoantigen

#227
20210041468
2021-02-11

NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY SEVERITY DETERMINING METHOD AND PROGNOSIS PREDICTING METHOD

#228
20210033625
2021-02-04

DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS

#229
20210024592
2021-01-28

Expression cassette and host cell for expressing a Vip3-interacting protein

#230
20210018512
2021-01-21

Methods for covalently binding a cell surface protein and a ligand

#231
20210018500
2021-01-21

Aptamer method

#232
20210017273
2021-01-21

ANTIBODY FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF

#233
20210009686
2021-01-14

Anti-claudin 18.2 antibodies

#234
20210009685
2021-01-14

Antibody specifically binding to FOLR1 and uses thereof

#235
20210003556
2021-01-07

IMPROVING ANTI-PD-1 CANCER THERAPY

#236
20210002610
2021-01-07

Methods for manufacturing T cells by direct sorting and compositions thereof

#237
20210002363
2021-01-07

Anti-folate receptor 1 antibodies and uses thereof

#238
20200407417
2020-12-31

Methods and devices for complexing target entities

#239
20200400672
2020-12-24

Reagents and Methods for Breast Cancer Detection

#240
20200400650
2020-12-24

METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS

#241
20200393462
2020-12-17

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

#242
20200392212
2020-12-17

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#243
20200386773
2020-12-10

ANTIBODY FOR DETECTING EARLY DAMAGE TO BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND USE THEREOF

#244
20200385462
2020-12-10

ANTIBODY FOR USE IN DETECTING EARLY-STAGE DAMAGE OF BLOOD BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF

#245
20200385460
2020-12-10

Diagnosis and therapy of cancer involving cancer stem cells

#246
20200384070
2020-12-10

Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases

#247
20200378981
2020-12-03

Ratios of sFlt-1 to P1GF or endoglin to P1GF as biomarkers for preeclampsia related adverse outcomes after birth

#248
20200363429
2020-11-19

Methods for the diagnosis and treatment of endometriosis

#249
20200355701
2020-11-12

Protein biomarker indicators of neurological injury and/or disease and methods of use thereof

#250
20200347464
2020-11-05

PSMA-based molecular-genetic reporter system

#251
20200341000
2020-10-29

METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS

#252
20200340995
2020-10-29

Approach for universal monitoring of minimal residual disease in acute myeloid leukemia

#253
20200339999
2020-10-29

Compositions and methods for modulating dysferlin expression

#254
20200333347
2020-10-22

Diagnostic Assays and Kits for Detection of Folate Receptor 1

#255
20200333335
2020-10-22

Biomarker detection methods and systems and kits for practicing same

#256
20200323948
2020-10-15

Treating Renal and Liver Dysfunction with TLR4 Antagonists

#257
20200319196
2020-10-08

USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE

#258
20200319192
2020-10-08

EXTRACTION OF CIRCULATING TUMOR CELLS

#259
20200318205
2020-10-08

Screening method for materials that suppress characteristic body odor of elderly people

#260
20200317810
2020-10-08

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof

#261
20200309776
2020-10-01

HLA G-MODIFIED CELLS AND METHODS

#262
20200300850
2020-09-24

Multiplexed diagnostic assay for iron and vitamin A deficiency and methods of use thereof

#263
20200299252
2020-09-24

Vitamin E-based amphipathic compound, and use thereof

#264
20200292561
2020-09-17

Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles

#265
20200292537
2020-09-17

Anti-pY1235-MET immunological binding reagent

#266
20200271665
2020-08-27

DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA

#267
20200271644
2020-08-27

Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor

#268
20200270687
2020-08-27

Cystic fibrosis transmembrane conductance regulator gene mutations

#269
20200264193
2020-08-20

DIAGNOSTIC MARKERS FOR BOVINE TUBERCULOSIS AND USES THEREOF

#270
20200264188
2020-08-20

PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS

#271
20200256873
2020-08-13

Methods for treating, preventing and predicting risk of developing breast cancer

#272
20200256871
2020-08-13

DETECTION OF T-CELLS EXPRESSING BTNL8

#273
20200256859
2020-08-13

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

#274
20200247866
2020-08-06

TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF

#275
20200241012
2020-07-30

RGMa Fragment Based Diagnostic Assay

#276
20200239593
2020-07-30

Means and methods for counteracting myeloproliferative or lymphoproliferative disorders

#277
20200239540
2020-07-30

CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)

#278
20200239539
2020-07-30

CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)

#279
20200225214
2020-07-16

Selection of agents modulating gastrointestinal pain

#280
20200209246
2020-07-02

Diagnostic method

#281
20200208159
2020-07-02

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

#282
20200207868
2020-07-02

HER3 binding agents and uses thereof

#283
20200200752
2020-06-25

COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS

#284
20200199225
2020-06-25

Biological binding molecule

#285
20200191776
2020-06-18

DIAGNOSTIC METHODS FOR NEURAL DISORDERS

#286
20200190184
2020-06-18

Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain

#287
20200182871
2020-06-11

Senescent cell biomarkers

#288
20200181568
2020-06-11

METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERM CELLS

#289
20200175846
2020-06-04

Configuring a Smart Home Controller

#290
20200174001
2020-06-04

METHODS AND COMPOSITIONS FOR SINGLE CHAIN VARIABLE REGION ENOX2 ANTIBODIES FOR CANCER DETECTION AND DIAGNOSIS

#291
20200141940
2020-05-07

Methods for cancer detection with quantum dots

#292
20200140541
2020-05-07

Antibodies that bind cell surface GRP78

#293
20200124603
2020-04-23

METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS

#294
20200123250
2020-04-23

Nucleic acid molecules encoding anti-GPRC5D antibodies

#295
20200123249
2020-04-23

METHODS OF TREATING CANCERS USING ANTI-GPRC5D ANTIBODIES

#296
20200123199
2020-04-23

Acetylcholine receptor-binding peptide

#297
20200115456
2020-04-16

Anti-galectin-7 antibody, kit comprising the same, and uses thereof

#298
20200115366
2020-04-16

Modulators of ATP-binding cassette transporters

#299
20200103419
2020-04-02

BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES

#300
20200101112
2020-04-02

Renal cell populations and uses thereof